SavedAdd your journal

Journals / Nöropsikiyatri Arşivi / 2012 / Cilt: 49 - Sayı: 4

Multipl skleroz prevelansı: Türkiye’nin kuzey doğusunda epidemiyolojik saha calışması

The prevalence of multiple sclerosis in the north caucasus region of Turkey: Door-to-door epidemiological field study

Recep ALP
SELEN İLHAN ALP
Yılmaz PLANCI
Zuhal YAPICI
Ülkü Türk BÖRÜ
Pages
272–275
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: This study, similar to the previous population-based study conducted in our country, demonstrated that the prevalence of MS in Turkey could be higher than expected. (Archives of Neuropsychiatry 2012; 49: 272-275)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: The prevalence rate of multiple sclerosis (MS) might differ between countries depending on whether the data is obtained from hospital-based or population-based studies.
📊
Key Findings & Data:Results: 7249 subjects were included in face-to-face interviews.
💡
Conclusion & Impact:Conclusion: This study, similar to the previous population-based study conducted in our country, demonstrated that the prevalence of MS in Turkey could be higher than expected. (Archives of Neuropsychiatry 2012; 49: 272-275)
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Background: The prevalence rate of multiple sclerosis (MS) might differ between countries depending on whether the data is obtained from hospital-based or population-based studies. This study aimed at identifying the prevalence of MS with face-to-face interviews by door-to-door field visits in a population study conducted in the north-eastern (Caucasus) part of Turkey situated at high altitude, with long winters and with inhabitants having low socio-economical status. Method: In this cross-sectional field study, one of every three houses within the city proper were visited searching for MS cases. Results: 7249 subjects were included in face-to-face interviews. Five patients diagnosed as having MS were identified. The prevalence of MS was calculated as 68.97/100000, with a mean age of 35.1±10.2 years and female to male ratio of 4/1. Conclusion: This study, similar to the previous population-based study conducted in our country, demonstrated that the prevalence of MS in Turkey could be higher than expected. (Archives of Neuropsychiatry 2012; 49: 272-275)

Özet

Amaç: Multipl skleroz (MS) prevelans oranı, yapılan çalışmaların toplum veya hastane kaynaklı olmasına bağlı olarak, ülkeler arasında farklılık göstermektedir. Bu çalışmamızda amacımız sosyoekonomik seviyesi düşük, coğrafi açıdan yüksek rakımda, mevsimsel olarak uzun süren kış aylarının olduğu ülkemizin kuzey-doğu illerinden Kars’ta, yüz yüze ve kapı kapı gezilerek, MS prevelansını tespit etmektir. Yöntem: Bu kesitsel alan çalışmasında, MS olgusu ararken tüm kentte belirlenen her üç evden birine ziyaret yapıldı. Bulgular: Toplam 7249 kişi ile yüz yüze görüşmeler yapıldı. MS tanısı konmuş 5 hasta tespit edildi. MS prevelansı 68,97/100000, kadın erkek oranı 4/1, hastaların yaş ortalaması 35,1±10,2 olarak hesaplandı. Sonuç: Bu çalışma, ülkemizde daha önce yapılan benzer çalışma ile benzer şekilde, MS prevelansının tahmin edilen değerden daha yüksek olabileceğini bize göstermektedir. (Nöropsikiyatri Arflivi 2012; 49: 272-275)

🔖

Cite This Article

ALP, R., ALP, S. İ., PLANCI, Y., YAPICI, Z., BÖRÜ, Ü. T. (2012). Multipl skleroz prevelansı: Türkiye’nin kuzey doğusunda epidemiyolojik saha calışması. Nöropsikiyatri Arşivi, Cilt: 49 - Sayı: 4, 272–275. https://ajindex.com/articles/292599

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Comi G, Filipi M, Wolinski JS. European/Canadian Multicenter, double-blind, randomized, placebo controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis. Ann Neurol 2001; 49:290-297
  2. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000; 343:938-952
  3. Kantarci OH, de Andrade M, Weinshenker BG. Identifying disease modi¬fying genes in multiple sclerosis. J Neuroimmunol 2002; 123:144-159
  4. World Health Organization and Multiple Sclerosis Internatinal Federation. Atlas Multiple Sclerosis Resorurces in The World. 2008: 14-15
  5. Nicoletti A, Patti F, Lo Fermo S, Sorbello V, Reggio E, Maimone D, Zappia M, Reggio A. Possible increasing risk of multiple sclerosis in Catania, Sicily. Neurology 2005; 65:1259-1263
  6. Türk Börü U, Alp R, Sur H, Gül L. Prevalence of Multiple Sclerosis Door-to- Door Survey in Maltepe, Istanbul, Turkey. Neuroepidemiology 2006; 27:17-21. Epub 2006 Jun 13
  7. Pugliatti M, Riise T, Sotgiu MA, Sotgiu S, Satta WM, Mannu L, Sanna G, Rosati G. Increasing incidence of multiple sclerosis in province Sassari, Northern Sardina. Neuroepidemiology 2005; 25:129-134
  8. Kurtzke JF. Multiple sclerosis in time and space-geographic clues to cause. J Neurovirol 2000; 6(suppl 2):2134–2140
  9. Fernández O, Luque G, San Román C, Bravo M, Dean G. The prevalence of multiple sclerosis in the Sanitary District of Vélez-Málaga, southern Spain. Neurology 1994; 44:425-429
  10. Kurtzke JF. Epidemiology contributions to multiple sclerosis: an overview. Neurology 1980; 30:61-79
  11. Kurtzke JF. Geographic distribution of multiple sclerosis: an update with special reference to Europe and the Mediterranean region. Acta Neurol Scand 1980; 62:65-80
  12. Çelik Y, Birgili O, Kıyat A, Guldiken B, Ozkan H, Yılmaz H, Saip S, Kuscu DY, Sutlas N, Agaoglu J, Utku U, Hayran O, Siva A ve Türk Multipl Skleroz çalışma Grubu: Edirne şehir merkezinde multiple skleroz prevalansı çalışması.(Abstract)
  13. Ulusal Noroloji Kongresi 22– 26 Ekim 2003 Antalya; 2003; s. 80
  14. Turkey census 2007. Available at: http://tuikapp.tuik.gov.tr/ adnksdagitapp/ adnks.zul. November 2008
  15. Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, Polman CH, Comi G, Ader HJ, Losseff N, Valk J. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120:2059-2069
  16. Tintoré